Publicação:
Beneficial effects of N-acetylcysteine on hepatic oxidative stress in streptozotocin-induced diabetic rats

dc.contributor.authorRosa, Lucas Rodolfo de Oliveira [UNESP]
dc.contributor.authorKaga, Anderson Kiyoshi [UNESP]
dc.contributor.authorBarbanera, Pedro Octavio [UNESP]
dc.contributor.authorQueiroz, Priscila Manfio [UNESP]
dc.contributor.authordo Carmo, Nágilla Orleanne Lima [UNESP]
dc.contributor.authorFernandes, Ana Angélica Henrique [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2018-12-11T17:36:32Z
dc.date.available2018-12-11T17:36:32Z
dc.date.issued2018-01-01
dc.description.abstractDiabetes is one of the leading diseases worldwide and, thus, finding new therapeutic alternatives is essential. The development of non-alcoholic fatty liver disease is a notable diabetic complication. Therefore, antioxidant therapy became a leading topic in the world of diabetes research. The objective of this present study was to evaluate the effects of antioxidant N-acetylcysteine (NAC) administration on serum biochemical parameters and oxidative stress parameters in hepatic tissue of the diabetic rats. Thirty-two animals were divided in 4 groups (n = 8): G1, normal rats; G2, normal rats + NAC; G3, diabetic rats; and G4, diabetic rats + NAC. Diabetes was induced in diabetic groups through streptozotocin. NAC administration was effective in improving hyperglycemia and hypoinsulinemia, as well as reducing serum alanine-aminotransferase and urea, hepatic triglycerides accumulation, and oxidative stress biomarkers in the diabetic liver, as well as improving the activity of hepatic antioxidant enzymes. This effect was likely due to NAC’s ability of restoring intracellular glutathione, an important compound for the antioxidant defense, as well as due to NAC’s direct antioxidant properties. Thus, NAC administration was useful for reducing hepatic oxidative stress and decreased the deposit of triacylglycerols, minimizing diabetic hepatic damage, making it a promising therapeutic adjuvant in the future.en
dc.description.affiliationDepartment of Chemistry and Biochemistry São Paulo State University (UNESP) Institute of Biosciences
dc.description.affiliationUnespDepartment of Chemistry and Biochemistry São Paulo State University (UNESP) Institute of Biosciences
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.format.extent412-418
dc.identifierhttp://dx.doi.org/10.1139/cjpp-2017-0559
dc.identifier.citationCanadian Journal of Physiology and Pharmacology, v. 96, n. 4, p. 412-418, 2018.
dc.identifier.doi10.1139/cjpp-2017-0559
dc.identifier.issn1205-7541
dc.identifier.issn0008-4212
dc.identifier.scopus2-s2.0-85044627825
dc.identifier.urihttp://hdl.handle.net/11449/179729
dc.language.isoeng
dc.relation.ispartofCanadian Journal of Physiology and Pharmacology
dc.relation.ispartofsjr0,724
dc.relation.ispartofsjr0,724
dc.rights.accessRightsAcesso aberto
dc.sourceScopus
dc.subjectAntioxidant
dc.subjectDiabetes
dc.subjectHepatic damage
dc.subjectN-acetylcysteine
dc.subjectNon-alcoholic fatty liver disease
dc.subjectOxidative stress
dc.subjectStreptozotocin
dc.titleBeneficial effects of N-acetylcysteine on hepatic oxidative stress in streptozotocin-induced diabetic ratsen
dc.typeArtigo
dspace.entity.typePublication
unesp.author.lattes0077247086732148[6]
unesp.campusUniversidade Estadual Paulista (Unesp), Instituto de Biociências, Botucatupt
unesp.departmentQuímica e Bioquímica - IBBpt

Arquivos